moneyheap
MTD · Analysis updated Nov 10, 2026, 6:00 PM ET
Why is Mettler-Toledo International (MTD) stock moving?
MTD closed at $1,751.38 on Nov 10, up about 4% from $1,684.64 on Oct 22. The Q3 report on Nov 5 beat estimates on both adjusted EPS ($12.57 vs $12.09) and sales ($1.094B vs $1.071B), and management raised FY2026 adjusted EPS guidance to $47.70-$47.90. The first FY2027 guide of $52.50-$53.50 sits above the $51.76 estimate. Full-year sales guidance of $4.227B is slightly below the $4.238B consensus, and Q4 guidance is roughly in line, so the beat is driven mainly by earnings rather than top-line upside. The stock fell about 2.6% to $1,679 on the day of the report, then gapped to a $1,806.58 intraday high on Nov 6 on the heaviest volume in the window (350,850 shares), but closed at $1,722 and has since recovered to the $1,750-$1,760 range. Analyst activity since Nov 9 is constructive: Barclays and Stifel raised targets to $1,900, Baird to $1,815, and JPMorgan to $1,840 (with a conflicting $1,725 figure), while Goldman's $1,640 target sits below the current price. Evercore's cut to $1,500 on Oct 28 predates the results. Growth is uneven: Americas sales rose only 3%, Europe was flat, and Asia Rest of World rose 16%. Some of the EPS gain reflects a one-time tariff refund, which limits how far the quarter can be extrapolated.
News behind the analysis
- Mettler-Toledo Intl Q3 Adj. EPS $12.57 Beats $12.09 Estimate, Sales $1.094B Beat $1.071B EstimateQ3 adjusted EPS of $12.57 topped estimates, and sales rose 6% to $1.094B. Local currency sales grew 6%, with Asia Rest of World up 14%.
- Mettler-Toledo Intl Raises FY2026 Adj EPS Guidance from $47.15-$47.50 to $47.70-$47.90 vs $47.35 Est; Raises FY2026 Sales Guidance from $4.187B-$4.227B to $4.227B vs $4.238B EstFull-year adjusted EPS guidance was raised to $47.70-$47.90, above the $47.35 estimate. The sales guidance of $4.227B sits slightly below the $4.238B estimate.
- Mettler-Toledo Intl Sees FY2027 Adj EPS $52.50-$53.50 vs $51.76 Est; Local currency sales for 2027 FY are expected to be up by 5% YoYFirst FY2027 guidance calls for adjusted EPS of $52.50-$53.50, above the $51.76 estimate, with local currency sales up about 5%.
- Barclays Maintains Overweight on Mettler-Toledo Intl, Raises Price Target to $1900Barclays keeps an Overweight rating and raises its price target to $1,900.
- Stifel Maintains Buy on Mettler-Toledo Intl, Raises Price Target to $1900Stifel keeps a Buy rating and lifts its price target from $1,600 to $1,900.
- JP Morgan Maintains Neutral on Mettler-Toledo Intl, Raises Price Target to $1840JPMorgan keeps a Neutral rating and raises its target to $1,840. A separate report on the same day cites a $1,725 target.
- Goldman Sachs Adjusts Price Target on Mettler-Toledo International to $1,640 From $1,510Goldman Sachs raises its price target to $1,640 from $1,510, still below the latest close.
- Mettler-Toledo Raises Full-Year 2026 Sales Outlook and Provides 2027 GuidanceThe company raised its 2026 sales growth forecast after a strong third quarter and issued initial 2027 guidance.
- Mettler-Toledo Reports Q3 2026 Financial ResultsSales rose 6% in Q3 2026, with diluted EPS of $12.29 versus $10.57 a year earlier. Part of the EPS gain is linked to a one-time tariff refund.
- Evercore ISI Adjusts Price Target on Mettler-Toledo International to $1,500 From $1,550Evercore ISI trimmed its price target to $1,500 from $1,550, the most recent bearish-leaning target in the set.
About Mettler-Toledo International
Mettler-Toledo is a Columbus, Ohio–based global supplier of precision instruments and services, best known for laboratory balances and industrial and retail weighing equipment, plus analytical instruments and product-inspection systems. It holds leading market positions, earns a large share of revenue from recurring service and consumables, and has historically posted high profit margins, with trailing-twelve-month revenue of roughly $4.1 billion as of mid-2026.
How it makes money
It sells precision instruments in three broad areas. Laboratory instruments (balances, pipettes, titrators, analytical tools) are the largest at roughly half of sales. Industrial weighing and product-inspection equipment (metal detection, X-ray, checkweighing) make up most of the rest, and food retail scales are a small share. Service, calibration and consumables add a large recurring stream, roughly a third of revenue. Customers include pharma and biotech, food makers, chemical companies and retailers. Sales are spread across the Americas, Europe and Asia, including a sizeable business in China.
What usually moves MTD
- Pharma and biotech lab spending
- Industrial and manufacturing capital spending, including automation
- Demand in China and emerging markets
- Currency swings and tariffs
- Pricing power and margin execution